Management of All Patients with Multiple Actinic Keratoses Requires Lifelong Follow-Up and Repeated Treatment Cycles: A 12-Year Prospective Observational Study of a Cohort of 81 Patients
Immunocompetent patients with mAKs require lifelong follow-up accompanied by repeated treatment cycles, as the clearance rates, regardless of the degree achieved after a single treatment cycle, tend to be temporary. These patients are at a heightened risk of developing skin tumors.
Authors
- Mariateresa Rossi (ORCID: https://orcid.org/0000-0002-5101-159X)
- Simone Soglia (ORCID: https://orcid.org/0000-0002-2882-2036)
- Marina Venturini (ORCID: https://orcid.org/0000-0001-6800-3695)
- Vincenzo Maione (ORCID: https://orcid.org/0000-0002-0420-5009)
- Stefano Bighetti (ORCID: https://orcid.org/0009-0006-2781-6909)
- Piergiacomo Calzavara‐Pinton (ORCID: https://orcid.org/0000-0002-0935-7204)
- Sara Rovaris (ORCID: https://orcid.org/0000-0001-5454-4220)
- Mariachiara Arisi (ORCID: https://orcid.org/0000-0001-6307-6174)
- Luca Bettolini (ORCID: https://orcid.org/0000-0003-4374-802X)
Institutions
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
- University of Brescia (IT)
Publication Details
- Journal
- Dermatology
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1159/000548336
- Citations
- 1
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35